Home
Centre for Cancer Biomarkers CCBIO
JUSS – CCBIO Junior Scientist Symposium

CCBIO Junior Scientist Symposium

Welcome to the first CCBIO Junior Scientist Symposium of the spring term 2022!

Illustration with an owl pointing at the event date.
Photo:
CCBIO/Coulorbox.com

Main content

Dear all

We are happy to welcome you all to the first CCBIO Junior Scientist Symposium for this semester, March 10th, 2022. We are very excited that Professor Klaus Pantel will join us live from Germany for the keynote lecture. Professor Pantel has done pioneer work in the field of circulating tumor cells and molecules, and in the keynote lecture he will tell us the story about how liquid biopsies moved from discovery to clinical implementation. 

Local junior researchers will present topics including personalized treatment in breast cancer, therapy resistance in CML, and cell population kinetics in kidney fibrosis. We will also hear about advanced techniques including mass cytometry and get an introduction of a pipeline for spatial analysis of the tumor microenvironment. 

We are very pleased to be able to finally meet in person, but the symposium will also be open for digital attendance. Please register within March 7th at 11.00 for those of you who want to attend in person. For digital attendance, you can register right up to the symposium day. 

Join us for a perfect occasion for professional input and networking!

Welcome!

Where: Hybrid solution with in-person attendance at Auditorium 4, BBB, and digitally through Zoom.

Registration: Through this link. Zoom link will be sent to those who are registered and did tick for Zoom.

Deadline: Within March 7th at 11.00 for those of you who want to attend in person. For digital attendance, you can register right up to the symposium day. 

Who: Open for all interested.

When: March 10, 2022, 09:00-13:00

Program:

09.00-09.15  Introduction

09.15-10.00  Keynote lecture by Professor Klaus Pantel: “Liquid Biopsy: From Discovery to Clinical Implementation”

10.00-10.30  Coffee break

10.30-10.55  Christina Engebrethsen: “Personalized treatment for HR+/HER2- locally advanced breast cancer”

10.55-11.20  Sturla Grøndal: “Studying cell population dynamics in kidney fibrosis with mass cytometry”

11.20-12.00  Lunch

12.00-12.25  Sina Takle: “Pipeline for spatial analysis of the tumor microenvironment”

12.25-12.50  Maria Omsland: “Investigation of a Nilotinib resistant CML cell line”

12.50-13.00  Concluding remarks